LMS Group Announces Consensus Conference on Cachexia

FOR IMMEDIATE RELEASE
(Free-Press-Release.com) July 15, 2008 -- The purpose of this conference entitled, "Determining Endpoints for Clinical Trials on Cachexia and Related Disorders" is to engage in a thorough discussion of the pros and cons of a variety of endpoints for trials intended to support the approval of new drugs designed to treat and prevent cachexia and related disorders. The goal is to work toward the establishment of a set of principles on current and future standards of efficacy and safety for these drugs.

1

LMS Group Announces Consensus Conference on Cachexia

Welcome visit Our WebSite:

http://www.lms-group.com

The primary focus will be on endpoints that are ready for incorporation into clinical trials now or in the near future. Participants may identify key issues and areas in which knowledge is limited and may recommend issues or questions for further study.

More than 20 international experts in Nutrition, Oncology, Cardiology, Nephrology, Geriatrics and other disciplines will meet on 8-9 December 2008 in Washington DC. www.cachexia.org

About LMS Group:

LMS is a leading medical education company generating positive changes in healthcare by encouraging scientific innovation, through a multidisciplinary approach that encompasses the development, dissemination and utilization of key knowledge. Filling the gap between evidence-based best clinical practice and what doctors actually do is LMS Group’s mission through development of Continuing Medical Education programs around the world. LMS Group was founded in 1998 by Eric-Jean Desbois, Chief Executive Officer and Yann Colardelle, Managing Director in an effort to improve the quality of medical education initiatives and, in turn, improve patient outcomes. Armine Najand, MD, Partner and Medical Director of LMS Group, takes the lead in science at LMS by developing multichannel, science-driven initiatives compliant with the latest CME regulations. LMS Group’s many years of collective experience covers areas as diverse as strategic publication planning to live symposia and e-learning platforms. LMS Group’s offices are located in Paris, France and New York, USA.

For additional information, please do not hesitate to contact Eric-Jean Desbois or Yann Colardelle of LMS Group at:

Tel: +33142530303
Fax: +33142530302
www.lms-group.com

More information can be found online at http://www.lms-group.com

cachexia     consensus conference     lms group     oncology     sarcopenia     wasting diseases     weight loss